Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) FCF Margin (2019 - 2025)

Historic FCF Margin for Neurogene (NGNE) over the last 6 years, with Q1 2025 value amounting to 26975.0%.

  • Neurogene's FCF Margin rose 233469300.0% to 26975.0% in Q1 2025 from the same period last year, while for Sep 2025 it was 98000.0%, marking a year-over-year increase of 1199380800.0%. This contributed to the annual value of 7720.11% for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Neurogene's FCF Margin stood at 26975.0%, which was up 233469300.0% from 1754.27% recorded in Q2 2024.
  • Neurogene's 5-year FCF Margin high stood at 454300.0% for Q1 2023, and its period low was 1754.27% during Q2 2024.
  • For the 3-year period, Neurogene's FCF Margin averaged around 120787.2%, with its median value being 15301.54% (2024).
  • In the last 5 years, Neurogene's FCF Margin plummeted by 2000000000bps in 2024 and then surged by 233469300bps in 2025.
  • Over the past 3 years, Neurogene's FCF Margin (Quarter) stood at 454300.0% in 2023, then crashed by -100bps to 1754.27% in 2024, then surged by 1638bps to 26975.0% in 2025.
  • Its FCF Margin was 26975.0% in Q1 2025, compared to 1754.27% in Q2 2024 and 3628.07% in Q1 2024.